Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06511752

Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia

The current study aims to examine the benefits of an education/support group program for individuals with progressive aphasia (caused by various etiologies, diagnoses) and their carepartners. The current study utilizes pre-, post-treatment, and follow-up assessments to measure effects of a psychoeducational support group and an implementation/communication skills training phase on measures of psychosocial function, communicative effectiveness and speech/language function. Analysis of study-specific surveys and semi-structured interviews will provide qualitative data regarding outcomes. Before beginning the education and support group, focus groups will be run in order to set priorities for the themes to be included in the education program. Participants will join via tele-based means if preferred and these participants may reside in the United States, or internationally including Mexico and Spain.

Recruiting

Interested in participating?

Request Info

Key information

About this study

Two educational/support group routes will be offered:

  • Progressive aphasia (PA) educational/support group or
  • Caregiver educational support group with an implementation phase (including their partner with PA).

The caregiver educational support group path will be delivered in two phases, whereas the PA educational support group path will only consist of the first phase. The first phase of the caregiver educational support group will focus on the educational support group and the second phase will consist of implementation and practice of strategies with feedback provided by the clinician.

The educational/support groups (Routes 1 and 2) will include opportunities for discussion of issues related to language-led dementia or progressive aphasia (e.g., coping with changes in cognition and language, use of strategies for effective communication) and education regarding the disorder provided by relevant experts (e.g., speech-language pathologists, licensed professional counselors), separately for carepartners and individuals with progressive aphasia.

The implementation phase (Route 2, only) will allow for practice of strategies and skills learned in the first phase.

The total amount of time participants will be involved in the study will be 9 months, inclusive of follow-up.

Phase 1. Timeline for the support group portion of the study: Participants will complete pre-treatment measures during a period of 1-2 weeks prior to their first meeting. After four months of twice monthly meetings, post-treatment measures will be completed within 1-2 weeks of treatment completion. Follow-up evaluation will take place at 3-months post-treatment.

Phase 2. Timeline for the implementation/dyad training portion of the study: Post-treatment assessment from Phase 1 will serve as pre-treatment assessment for Phase 2. Treatment sessions will be held once weekly for 4 weeks, and post-treatment assessment will be completed within 1-2 weeks of phase 2 treatment completion. Follow-up evaluation will take place at 3-months post-treatment.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All participants must:

  • speak Spanish and/or English (although participants may speak other languages in addition to Spanish and/or English)
  • identify as Hispanic and/or Latinx,
  • or their spouse/family member with PA identifies as Hispanic and/or Latinx
  • see and hear well enough to participate
  • have access to a computer or mobile device with video capability
  • have an internet connection

Additional inclusion criteria for PA/ language-led dementia support group participants:

  • Individuals with PA:
  • Has a diagnosis of PA, or language-led dementia, and aphasia is one of the primary causes of difficulty with activities of daily living
  • Aware of language difficulties and willing to discuss them
  • Able to actively engage in group discussion and complete activities with minimal support
  • Able to regularly attend meetings
  • Willing to follow the rules of the support group for interacting with others respectfully

Additional inclusion criteria for care partner support group plus implementation phase participants:

  • Individuals with PA:
  • Diagnosis of aphasia or dementia that is progressive in nature, and aphasia is one of the primary causes of difficulty with activities of daily living
  • Have some ability to communicate and understand communication in order to participate in training sessions
  • Are functionally able to engage in training sessions (e.g., able to maintain some attention, minimal challenging behavior that would cause disruption)
  • Have a care partner who also consents to participating in the project
  • Care partners:
  • Self-identification as a caregiver of an individual with a diagnosis of PA or language-led dementia
  • Willing to discuss caregiving for individuals with PA/ language-led dementia
  • Able to regularly attend meetings
  • Willing to follow the rules of the support group for interacting with others respectfully

Exclusion criteria

  • Beyond the inclusion criteria included above, no additional exclusion criteria apply

Treatment and study plan

Psychosocial educational, support group and implementation of strategies

Behavioral

Psychosocial educational, support group and implementation of strategies

Primary outcomes

  1. Treatment/Acceptability Survey

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    In-house Acceptability and Perception of Change Survey

Secondary outcomes

  1. Acceptability Measure

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    Acceptability scale for healthcare interventions (the Theoretical Framework of Acceptability based questionnaire; Sekhon et al., 2022)

  2. % participants who complete intervention, % sessions completed

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    Adherence/receipt of intervention, 0-100, greater better

  3. % completion of homework

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    Engagement, 0-100, greater better

  4. Retention

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    Number of dropouts, reasons for dropout (related to intervention or not), and overall, retention rate at final assessment and follow-up; 80% is successful at the final post-treatment assessment and 80% is successful at the 2-month follow-up, 0-100, greater better

  5. Aphasia Impact Questionnaire

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    Aphasia impact, Higher score indicates poorer quality of life (worse) Range of scores for each question: 0-4 Total 0-84

  6. Mini-Mental State Exam

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    Cognitive screener, 0-30, greater better

  7. Quick Aphasia Battery

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    Aphasia severity, 0-10, greater better

  8. Stroke and Aphasia Quality of Life Scale- 39

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    Quality of life, greater score is better, 0-195

  9. Progressive Aphasia Severity Scale (PASS)

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    Aphasia severity, higher score = worse, 0-3

  10. The Neuropsychiatric Inventory

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    Neuropsychiatric status, higher score = worse, 0-36

  11. Clinical Dementia Rating Scale (CDR)

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    Dementia Rating, higher score = worse, 0-3

  12. Quality of the Caregiver Patient Relationship (QCPR)

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    Quality of life, higher scores is better,14-70

  13. Dementia Quality of Life

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    Quality of life, higher score is better, 28-112

  14. Geriatric Depression Scale

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    Depression, higher score is worse, 0-15

  15. Dementia Knowledge Assessment Scale

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    Dementia Knowledge, higher score is better, 0-60

  16. Center for Epidemiologic Studies Depression Scale

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    Depression, higher score is worse, 0- 60

  17. Cuestionario de Salud 36-Item Short Form Survey Instrument

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    General health, higher score is better, 0-100

  18. General Anxiety Disorder-7

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    Anxiety, higher score is worse, 0-21

  19. The Duke University Religion Index

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    Religion Index

  20. Familism Scale

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    Familism Scale, higher score= greater religiosity, 1-15 considering all subscales

  21. Acculturation Rating Scale for Mexican Americans

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    Acculturation, higher score is better, 20-124

  22. Adult Carer Quality of Life Questionnaire

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    Quality of Life, higher score is better, 0 -105

  23. Brief COPE

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    Coping strategies, higher score is better, 0-6

  24. Brief Assessment Scale for Caregivers

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    Coping strategies, higher score = worse, -28-28

  25. Zarit Burden Interview

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    Burden, higher score = worse, 0-88

  26. Perceived Stress Scale

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    Stress level, higher = worse, 0-40

  27. Devereux Adult Resilience Scale

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    Resilience

  28. Dementia Management Strategies Scale (Tan et al., 2013)

    Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

    Dementia management, higher score= higher frequency of action, subscales 8-55

Study contacts

Contact information is provided by the study sponsor or research team.

Stephanie M Grasso, PhD

CONTACT

[email protected]

6268648957

Sponsors and collaborators

Lead sponsor

University of Texas at Austin

Other

Collaborators

  • The Association for Frontotemporal Degeneration

Registry information

Official study title

Educational Support Group Program for Carepartners of Bilingual and Spanish-speaking Persons With Progressive Forms of Aphasia and for Persons With Progressive Forms of Aphasia

Important dates

Study start
2024
Primary completion
2030
Study completion
2030
First posted
Jul 22, 2024
Registry last updated
Jun 10, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.